In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation

The search for target antigens for CAR-T cell therapy against multiple myeloma defined the B-cell maturation antigen (BCMA) as an interesting candidate. Several studies with BCMA-directed CAR-T cell therapy showed promising results. Second-generation point-of-care BCMA.CAR-T cells were manufactured...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Jiang, Genqiao (VerfasserIn) , Neuber, Brigitte (VerfasserIn) , Hückelhoven-Krauss, Angela (VerfasserIn) , Höpken, Uta (VerfasserIn) , Ding, Yuntian (VerfasserIn) , Sedloev, David (VerfasserIn) , Wang, Lei (VerfasserIn) , Reichman, Avinoam (VerfasserIn) , Eberhardt, Franziska (VerfasserIn) , Wermke, Martin (VerfasserIn) , Rehm, Armin (VerfasserIn) , Müller-Tidow, Carsten (VerfasserIn) , Schmitt, Anita (VerfasserIn) , Schmitt, Michael (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 23 January 2024
In: International journal of molecular sciences
Year: 2024, Jahrgang: 25, Heft: 3, Pages: 1-15
ISSN:1422-0067
DOI:10.3390/ijms25031394
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/ijms25031394
Verlag, kostenfrei, Volltext: https://www.mdpi.com/1422-0067/25/3/1394
Volltext
Verfasserangaben:Genqiao Jiang, Brigitte Neuber, Angela Hückelhoven-Krauss, Uta E. Höpken, Yuntian Ding, David Sedloev, Lei Wang, Avinoam Reichman, Franziska Eberhardt, Martin Wermke, Armin Rehm, Carsten Müller-Tidow, Anita Schmitt and Michael Schmitt

MARC

LEADER 00000caa a2200000 c 4500
001 1891059165
003 DE-627
005 20241205141806.0
007 cr uuu---uuuuu
008 240611s2024 xx |||||o 00| ||eng c
024 7 |a 10.3390/ijms25031394  |2 doi 
035 |a (DE-627)1891059165 
035 |a (DE-599)KXP1891059165 
035 |a (OCoLC)1475299473 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Jiang, Genqiao  |d 1994-  |e VerfasserIn  |0 (DE-588)1253805423  |0 (DE-627)1796134635  |4 aut 
245 1 0 |a In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation  |c Genqiao Jiang, Brigitte Neuber, Angela Hückelhoven-Krauss, Uta E. Höpken, Yuntian Ding, David Sedloev, Lei Wang, Avinoam Reichman, Franziska Eberhardt, Martin Wermke, Armin Rehm, Carsten Müller-Tidow, Anita Schmitt and Michael Schmitt 
264 1 |c 23 January 2024 
300 |b Illustrationen 
300 |a 15 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 11.06.2024 
520 |a The search for target antigens for CAR-T cell therapy against multiple myeloma defined the B-cell maturation antigen (BCMA) as an interesting candidate. Several studies with BCMA-directed CAR-T cell therapy showed promising results. Second-generation point-of-care BCMA.CAR-T cells were manufactured to be of a GMP (good manufacturing practice) standard using the CliniMACS Prodigy® device. Cytokine release in BCMA.CAR-T cells after stimulation with BCMA positive versus negative myeloma cell lines, U266/HL60, was assessed via intracellular staining and flow cytometry. The short-term cytotoxic potency of CAR-T cells was evaluated by chromium-51 release, while the long-term potency used co-culture (3 days/round) at effector/target cell ratios of 1:1 and 1:4. To evaluate the activation and exhaustion of CAR-T cells, exhaustion markers were assessed via flow cytometry. Stability was tested through a comparison of these evaluations at different timepoints: d0 as well as d + 14, d + 90 and d + 365 of cryopreservation. As results, (1) Killing efficiency of U266 cells correlated with the dose of CAR-T cells in a classical 4 h chromium-release assay. There was no significant difference after cryopreservation on different timepoints. (2) In terms of endurance of BCMA.CAR-T cell function, BCMA.CAR-T cells kept their ability to kill all tumor cells over six rounds of co-culture. (3) BCMA.CAR-T cells released high amounts of cytokines upon stimulation with tumor cells. There was no significant difference in cytokine release after cryopreservation. According to the results, BCMA.CAR-T cells manufactured under GMP conditions exerted robust and specific killing of target tumor cells with a high release of cytokines. Even after 1 year of cryopreservation, cytotoxic functions were maintained at the same level. This gives clinicians sufficient time to adjust the timepoint of BCMA.CAR-T cell application to the patient’s course of the underlying disease. 
650 4 |a B-cell maturation antigen (BCMA) 
650 4 |a CAR-T cells 
650 4 |a multiple myeloma 
650 4 |a stability and function of CAR-T cells 
650 4 |a timepoint 
700 1 |a Neuber, Brigitte  |d 1974-  |e VerfasserIn  |0 (DE-588)1052913563  |0 (DE-627)789293188  |0 (DE-576)408653884  |4 aut 
700 1 |a Hückelhoven-Krauss, Angela  |d 1983-  |e VerfasserIn  |0 (DE-588)1034095889  |0 (DE-627)744057280  |0 (DE-576)381742822  |4 aut 
700 1 |a Höpken, Uta  |d 1964-  |e VerfasserIn  |0 (DE-588)172796407  |0 (DE-627)697727025  |0 (DE-576)133652882  |4 aut 
700 1 |a Ding, Yuntian  |d 1993-  |e VerfasserIn  |0 (DE-588)1259371743  |0 (DE-627)1806275392  |4 aut 
700 1 |a Sedloev, David  |e VerfasserIn  |0 (DE-588)1252255403  |0 (DE-627)1793382204  |4 aut 
700 1 |a Wang, Lei  |d 1985-  |e VerfasserIn  |0 (DE-588)1076031994  |0 (DE-627)834093308  |0 (DE-576)444802398  |4 aut 
700 1 |a Reichman, Avinoam  |d 1992-  |e VerfasserIn  |0 (DE-588)1253804664  |0 (DE-627)1796132659  |4 aut 
700 1 |a Eberhardt, Franziska  |e VerfasserIn  |0 (DE-588)1298854555  |0 (DE-627)1854976990  |4 aut 
700 1 |a Wermke, Martin  |d 1978-  |e VerfasserIn  |0 (DE-588)1143166787  |0 (DE-627)1002562465  |0 (DE-576)494958294  |4 aut 
700 1 |a Rehm, Armin  |e VerfasserIn  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
700 1 |a Schmitt, Anita  |d 1969-  |e VerfasserIn  |0 (DE-588)141722495  |0 (DE-627)630587752  |0 (DE-576)325593892  |4 aut 
700 1 |a Schmitt, Michael  |d 1966-  |e VerfasserIn  |0 (DE-588)133177173  |0 (DE-627)538000600  |0 (DE-576)299672921  |4 aut 
773 0 8 |i Enthalten in  |t International journal of molecular sciences  |d Basel : Molecular Diversity Preservation International, 2000  |g 25(2024), 3, Artikel-ID 1394, Seite 1-15  |h Online-Ressource  |w (DE-627)316340715  |w (DE-600)2019364-6  |w (DE-576)281194653  |x 1422-0067  |7 nnas  |a In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation 
773 1 8 |g volume:25  |g year:2024  |g number:3  |g elocationid:1394  |g pages:1-15  |g extent:15  |a In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation 
856 4 0 |u https://doi.org/10.3390/ijms25031394  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/1422-0067/25/3/1394  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20240611 
993 |a Article 
994 |a 2024 
998 |g 133177173  |a Schmitt, Michael  |m 133177173:Schmitt, Michael  |d 910000  |d 910100  |e 910000PS133177173  |e 910100PS133177173  |k 0/910000/  |k 1/910000/910100/  |p 14  |y j 
998 |g 141722495  |a Schmitt, Anita  |m 141722495:Schmitt, Anita  |d 910000  |d 910100  |d 50000  |e 910000PS141722495  |e 910100PS141722495  |e 50000PS141722495  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 13 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 12 
998 |g 1253804664  |a Reichman, Avinoam  |m 1253804664:Reichman, Avinoam  |d 50000  |e 50000PR1253804664  |k 0/50000/  |p 8 
998 |g 1252255403  |a Sedloev, David  |m 1252255403:Sedloev, David  |p 6 
998 |g 1259371743  |a Ding, Yuntian  |m 1259371743:Ding, Yuntian  |d 50000  |e 50000PD1259371743  |k 0/50000/  |p 5 
998 |g 1034095889  |a Hückelhoven-Krauss, Angela  |m 1034095889:Hückelhoven-Krauss, Angela  |d 910000  |d 910100  |e 910000PH1034095889  |e 910100PH1034095889  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 1052913563  |a Neuber, Brigitte  |m 1052913563:Neuber, Brigitte  |d 910000  |d 910100  |e 910000PN1052913563  |e 910100PN1052913563  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1253805423  |a Jiang, Genqiao  |m 1253805423:Jiang, Genqiao  |d 50000  |e 50000PJ1253805423  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1891059165  |e 4536307346 
BIB |a Y 
SER |a journal 
JSO |a {"language":["eng"],"physDesc":[{"extent":"15 S.","noteIll":"Illustrationen"}],"origin":[{"dateIssuedDisp":"23 January 2024","dateIssuedKey":"2024"}],"type":{"media":"Online-Ressource","bibl":"article-journal"},"person":[{"given":"Genqiao","roleDisplay":"VerfasserIn","display":"Jiang, Genqiao","role":"aut","family":"Jiang"},{"role":"aut","family":"Neuber","display":"Neuber, Brigitte","roleDisplay":"VerfasserIn","given":"Brigitte"},{"given":"Angela","display":"Hückelhoven-Krauss, Angela","roleDisplay":"VerfasserIn","family":"Hückelhoven-Krauss","role":"aut"},{"family":"Höpken","role":"aut","given":"Uta","display":"Höpken, Uta","roleDisplay":"VerfasserIn"},{"given":"Yuntian","display":"Ding, Yuntian","roleDisplay":"VerfasserIn","family":"Ding","role":"aut"},{"family":"Sedloev","role":"aut","roleDisplay":"VerfasserIn","display":"Sedloev, David","given":"David"},{"given":"Lei","roleDisplay":"VerfasserIn","display":"Wang, Lei","role":"aut","family":"Wang"},{"family":"Reichman","role":"aut","given":"Avinoam","display":"Reichman, Avinoam","roleDisplay":"VerfasserIn"},{"family":"Eberhardt","role":"aut","given":"Franziska","roleDisplay":"VerfasserIn","display":"Eberhardt, Franziska"},{"role":"aut","family":"Wermke","given":"Martin","display":"Wermke, Martin","roleDisplay":"VerfasserIn"},{"family":"Rehm","role":"aut","given":"Armin","display":"Rehm, Armin","roleDisplay":"VerfasserIn"},{"given":"Carsten","display":"Müller-Tidow, Carsten","roleDisplay":"VerfasserIn","family":"Müller-Tidow","role":"aut"},{"display":"Schmitt, Anita","roleDisplay":"VerfasserIn","given":"Anita","role":"aut","family":"Schmitt"},{"given":"Michael","roleDisplay":"VerfasserIn","display":"Schmitt, Michael","family":"Schmitt","role":"aut"}],"id":{"eki":["1891059165"],"doi":["10.3390/ijms25031394"]},"recId":"1891059165","relHost":[{"language":["eng"],"physDesc":[{"extent":"Online-Ressource"}],"type":{"media":"Online-Ressource","bibl":"periodical"},"origin":[{"publisherPlace":"Basel","dateIssuedKey":"2000","dateIssuedDisp":"2000-","publisher":"Molecular Diversity Preservation International"}],"part":{"text":"25(2024), 3, Artikel-ID 1394, Seite 1-15","pages":"1-15","issue":"3","extent":"15","volume":"25","year":"2024"},"recId":"316340715","pubHistory":["1.2000 -"],"id":{"issn":["1422-0067","1661-6596"],"zdb":["2019364-6"],"eki":["316340715"]},"titleAlt":[{"title":"IJMS"}],"disp":"In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservationInternational journal of molecular sciences","note":["Gesehen am 17.09.20"],"title":[{"title":"International journal of molecular sciences","title_sort":"International journal of molecular sciences"}]}],"title":[{"title_sort":"In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation","title":"In vitro functionality and endurance of GMP-compliant point-of-care BCMA.CAR-T cells at different timepoints of cryopreservation"}],"name":{"displayForm":["Genqiao Jiang, Brigitte Neuber, Angela Hückelhoven-Krauss, Uta E. Höpken, Yuntian Ding, David Sedloev, Lei Wang, Avinoam Reichman, Franziska Eberhardt, Martin Wermke, Armin Rehm, Carsten Müller-Tidow, Anita Schmitt and Michael Schmitt"]},"note":["Gesehen am 11.06.2024"]} 
SRT |a JIANGGENQIINVITROFUN2320